Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05923996
Other study ID # treatment of wide facial pores
Secondary ID
Status Not yet recruiting
Phase Phase 1
First received
Last updated
Start date February 1, 2024
Est. completion date August 1, 2024

Study information

Verified date December 2023
Source Assiut University
Contact Ahmed AE Ibrahim
Phone 01200889665
Email ahmedalaa12494@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

1. Evaluation of fractional Co2 laser as a treatment option for wide pores in skin type (III - VI) 2. Evaluation of mesobotox as a new modality for improving wide pores appearance. 3. Comparison of both treatment modalities in treatment of enlarged pores.


Description:

Skin pores (SP), as they are called by laymen, are common and benign features mostly located on the face (nose, cheeks, etc) that generate many aesthetic concerns or complaints. Enlarged skin pores refer to conditions that present with visible topographic changes of skin surfaces. Although not a medical concern, enlarged pores are a cosmetic concern for a large number of individuals. Enlarged facial pores affect individuals of different ages, sexes, and races for which many seek treatment. The exact patho-mechanism of enlarged facial pores is not completely understood. Possible causes include genetic predisposition, seborrhea, aging, increased ultraviolet exposure and comedogenic products. The treatment of dilated facial pores is difficult, and the ideal modality is not established yet. Many treatment modalities reduce facial pores' count and area, including oral and topical medications as well as different wavelengths of laser. Different ablative and non ablative lasers have been used in the treatment of dilated pores with variable outcomes. The short-term results showed that treatment with low energy level CO2 fractional laser therapy could be a safe and effective option for patients with Fitzpatrick skin Types III and IV who are concerned with enlarged pores. Microbotox also called mesobotox, is the injection of multiple microdroplets of diluted onabotulinum toxin A into the upper dermis. It has been previously used in study to decrease pore size and to improve skin texture. Microbotox has been proved to be effective in improving the sheen and texture of the skin, as well as decreasing sweat and sebum production and enlarged pores as it causes atrophy of sebaceous glands, which subsequently causes tightening of the skin envelope.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 21
Est. completion date August 1, 2024
Est. primary completion date June 1, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: 1. Patient with wide facial pores any grade. 2. Sex: male and female patient. 3. Age groups: patient above 18 and below 45 years old. 4. Co-operative patient. Exclusion Criteria: 1. Patient below 18 and above 45 years old. 2. Patient with systemic illness or other dermatological disease. 3. Patient who receive topical treatment for facial wide pores in past month. 4. Patient who receive systemic treatment for facial wide pores in past 2 month.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
microbotox
Will be treated by single session of microbotox injection
Radiation:
fractional carbon dioxide laser
Two sessions of the fractional CO2 laser on this side of the face at 4-weeks intervals

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

References & Publications (9)

Ahmed El Attar Y, Nofal A. Microbotox for the treatment of wide facial pores: A promising therapeutic approach. J Cosmet Dermatol. 2021 May;20(5):1361-1366. doi: 10.1111/jocd.13675. Epub 2020 Sep 27. — View Citation

Eldeeb F, Wahid RM, Alakad R. Fractional carbon dioxide laser versus carbon-assisted Q-switched Nd: YAG laser in the treatment of dilated facial pores. J Cosmet Dermatol. 2021 Dec;20(12):3917-3923. doi: 10.1111/jocd.14311. Epub 2021 Jul 1. — View Citation

Flament F, Francois G, Qiu H, Ye C, Hanaya T, Batisse D, Cointereau-Chardon S, Seixas MD, Dal Belo SE, Bazin R. Facial skin pores: a multiethnic study. Clin Cosmet Investig Dermatol. 2015 Feb 16;8:85-93. doi: 10.2147/CCID.S74401. eCollection 2015. — View Citation

Kwon HH, Choi SC, Lee WY, Jung JY, Park GH. Clinical and Histological Evaluations of Enlarged Facial Skin Pores After Low Energy Level Treatments With Fractional Carbon Dioxide Laser in Korean Patients. Dermatol Surg. 2018 Mar;44(3):405-412. doi: 10.1097/DSS.0000000000001313. — View Citation

Lee SJ, Seok J, Jeong SY, Park KY, Li K, Seo SJ. Facial Pores: Definition, Causes, and Treatment Options. Dermatol Surg. 2016 Mar;42(3):277-85. doi: 10.1097/DSS.0000000000000657. — View Citation

Saedi N, Petrell K, Arndt K, Dover J. Evaluating facial pores and skin texture after low-energy nonablative fractional 1440-nm laser treatments. J Am Acad Dermatol. 2013 Jan;68(1):113-8. doi: 10.1016/j.jaad.2012.08.041. Epub 2012 Oct 23. — View Citation

Salem RM, Salah SAE, Ibrahim SE. Microbotox injection versus its topical application following microneedling in the treatment of wide facial pores: A split face comparative study. J Cosmet Dermatol. 2023 Apr;22(4):1249-1255. doi: 10.1111/jocd.15590. Epub 2023 Jan 6. — View Citation

Sayed KS, Hegazy R, Gawdat HI, Abdel Hay RM, Ahmed MM, Mohammed FN, Allam R, Fahim A. The efficacy of intradermal injections of botulinum toxin in the management of enlarged facial pores and seborrhea: a split face-controlled study. J Dermatolog Treat. 2021 Nov;32(7):771-777. doi: 10.1080/09546634.2019.1708241. Epub 2020 Jan 3. — View Citation

Tarek E, Mostafa WZ, Allam RSHM, El-Samanoudy SI, Saadi DG. Short-pulsed and Q-switched ND-YAG laser with topical carbon versus fractional CO2 laser in the treatment of enlarged facial pores: A split-face comparative study. Lasers Surg Med. 2022 Feb;54(2):237-244. doi: 10.1002/lsm.23454. Epub 2021 Jul 13. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary pore score evaluation of facial pores after four weeks of second session by pore score: score "0" referred to absence of visible pores. score "1" referred to patients with visible pores. score "2" referred to patient with enlarged pores. score "3" referred to patient with black heads when embedded on facial pores. three months
Primary sebum score evaluation the degree of seborea after four weeks of second session by sebum score: 0 (dry skin)
(mild oiliness)
(moderate oiliness)
(severe oiliness)
three months
Primary Quartile improvement scale assessment the improvement after four weeks of first session and after four weeks of second session by Quartile improvement scale: 0 = No improvement
= Minor/mild improvement (1%-25%)
= Moderate improvement (26%-50%)
= Marked improvement (51%-75%)
= Very significant improvement (76%-100%)
three months
Secondary Likert satisfaction scale = Very dissatisfied
= Dissatisfied
= Neither satisfied
= Satisfied
= Very satisfied
three months
See also
  Status Clinical Trial Phase
Completed NCT04539886 - Comparative Study Between CellFX and Electrodessication in Sebaceous Hyperplasia (SH) Lesions N/A
Completed NCT01407770 - Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer
Completed NCT05619471 - VIO Imaging for Skin Tissue Assessment (VISTA) N/A
Not yet recruiting NCT05554523 - How Does Skin Tone Affect Quantitative Photoacoustic Imaging
Completed NCT04872946 - Topical and Oral Regimen for Skin Health N/A
Completed NCT04449159 - Efficacy of Vinh Wellness Collagen on Skin Health N/A
Completed NCT03002194 - Change in Skin Elasticity With RF and PEMF N/A
Recruiting NCT06425068 - Assessment of an Innovative Air Mattress On Critically Ill Infants N/A
Enrolling by invitation NCT04934254 - THE NEWBORN SKIN ASSESSMENT ATTITUDE SCALE
Completed NCT05410964 - Non-Linear Imaging of Skin In Vivo
Completed NCT03612570 - Nano-Pulse Stimulation (NPS) in Sebaceous Hyperplasia N/A
Withdrawn NCT03862872 - Effects of Bend Beauty's Anti-Aging Formula on Inflammatory Markers N/A
Terminated NCT04253418 - Nano-Pulse Stimulation (NPS) in Sebaceous Hyperplasia Optimization Study N/A
Recruiting NCT04525521 - Hand Sanitizer Effects on the Skin Barrier
Withdrawn NCT01801878 - Pilot Study of Skin Quality Improvement After Adipose-drived Stem Cell Transfer in Irradiated Breasts N/A
Completed NCT00839280 - Moisturizing Effect of Two Dexpanthenol Formulations Phase 2
Completed NCT00520910 - Efficacy of Polypodium Leucotomos Extract Decreasing UVA Premutagenic and Photoaging Markers Phase 2
Completed NCT04813887 - Skin Diseases and Pregnancy: Which Heathcare Professionals ?
Recruiting NCT05641168 - A Pilot Evaluation Exploring New Adhesive Materials and Their Ability to Adhere to Abdominal and Peristomal Skin N/A
Terminated NCT01108523 - Evaluation of Effects of HP828-101 for Moisture Associated Skin Damage Phase 0